Skip to main content

Table 5 Reported benefit of BIS for patients with non-malignant conditions

From: The clinical and cost effectiveness of a Breathlessness Intervention Service for patients with advanced non-malignant disease and their informal carers: mixed findings of a mixed method randomised controlled trial

Results of categorisation of t3 (intervention arm: fast track) and t5 (control arm: waiting list) patient and carer qualitative interviews into levels of impact (Impact Categorisation Levels)

Level 1:

Significant impact – clearly stated BIS made a difference

Level 2:

Some impact – no major change recognised, but valued specific aspects of BIS

Level 3:

No impact – BIS made no difference at all

56 % (44/78)

36 % (28/78)

8 % (6/78)

  1. (no qualitative interview for one patient)
Back to article page

Trials

ISSN: 1745-6215